Efficacy and Safety of Depemokimab in the Treatment of Patients With Severe Asthma With an Eosinophilic Phenotype
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Twice-Yearly Depemokimab in Severe Asthma with an Eosinophilic Phenotype
N. Engl. J. Med 2024 Sep 09;[EPub Ahead of Print], DJ Jackson, ME Wechsler, DJ Jackson, D Bernstein, S Korn, PE Pfeffer, R Chen, J Saito, G de Luíz Martinez, L Dymek, L Jacques, N Bird, S Schalkwijk, D Smith, P Howarth, ID PavordFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.